Page last updated: 2024-12-10

1,5-anhydroglucitol-6-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## 1,5-Anhydroglucitol-6-phosphate (1,5-AG-6-P)

**What is it?**

1,5-Anhydroglucitol-6-phosphate (1,5-AG-6-P) is a **phosphorylated form of 1,5-anhydroglucitol (1,5-AG)**, a naturally occurring sugar alcohol found in humans and animals. It is synthesized from glucose in the liver and is primarily found in the blood and urine.

**How is it formed?**

1,5-AG is produced by the enzyme aldose reductase from glucose. Once formed, 1,5-AG is further phosphorylated by hexokinase to produce 1,5-AG-6-P.

**Why is it important for research?**

1,5-AG-6-P is an important research tool because it plays a critical role in **glucose homeostasis** and is a **potential biomarker for type 2 diabetes**.

**Key aspects of its research importance:**

* **Reflects long-term blood glucose levels:** 1,5-AG-6-P is taken up by cells and its levels in the blood reflect the average blood glucose levels over the preceding 1-2 weeks. This makes it a valuable tool for understanding long-term glucose control in patients.
* **Potential biomarker for type 2 diabetes:** 1,5-AG-6-P levels are often lower in individuals with type 2 diabetes. Researchers are investigating its potential as a reliable biomarker for early detection and monitoring of the disease.
* **Mechanism of action in glucose control:** 1,5-AG-6-P is thought to act as a competitive inhibitor of hexokinase, the enzyme that phosphorylates glucose. This inhibition could contribute to the regulation of glucose uptake and metabolism.
* **Insights into glucose metabolism:** Studying 1,5-AG-6-P pathways provides valuable information on the complex mechanisms involved in glucose homeostasis, including its interaction with other metabolic processes.
* **Therapeutic potential:** Further research on 1,5-AG-6-P's role in glucose control could lead to the development of new treatments for diabetes and other metabolic disorders.

**Current research:**

Ongoing research is focusing on:

* Elucidating the precise mechanisms by which 1,5-AG-6-P regulates glucose metabolism.
* Validating its effectiveness as a biomarker for type 2 diabetes diagnosis and monitoring.
* Exploring the potential of 1,5-AG-6-P as a therapeutic target for managing diabetes.

In conclusion, 1,5-AG-6-P is a fascinating molecule with significant implications for our understanding of glucose homeostasis and the development of new diagnostic and therapeutic tools for diabetes.

Cross-References

ID SourceID
PubMed CID3081444
SCHEMBL ID247669
MeSH IDM0040097

Synonyms (8)

Synonym
17659-59-5
d-glucitol, 1,5-anhydro-, 6-(dihydrogen phosphate)
1,5-anhydroglucitol-6-phosphate
[(2r,3s,4r,5s)-3,4,5-trihydroxyoxan-2-yl]methyl dihydrogen phosphate
1,5-anhydro-6-o-phosphono-d-glucitol
SCHEMBL247669
DTXSID20170158
Q27451489
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's0 (0.00)24.3611
2020's2 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies1 (14.29%)4.05%
Observational0 (0.00%)0.25%
Other5 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]